Search

The article discusses a study on the use of laser scleral microporation (LSM) to reverse sclera aging and restore ciliary muscles and lens movement as of 2023. Results show that most patients achieved near-vision improvements within the first week, with continued monthly improvements and sustenance over 24 months, and the absence complications other than occasional subconjunctival hematoma which resolved within 2 weeks. Also noted is the relative ease in performing the LSM procedure.

The article focuses on the use of corticosteroids for treatment of intraocular inflammation. Topics discussed include the increased intraocular pressure (IOP) in the use of corticosteroids, the application of steroid ointments such as Lotemax ointment, fluorometholone (FML) ointment, and triamcinolone cream, and the clinical efficacy of several steroids such as Lotemax gel, generic prednisolone acetate, and generic prednisolone sodium phosphate.

This case study provides a critical analysis of the management of a patient with long-term conditions in a community matron service. Particular attention is given to the effect of chronic obstructive pulmonary disease (COPD). The effect of COPD on health and wellbeing, quality of life and hospital admissions is examined, and outcomes are detailed that resulted from the implementation of evidence-based interventions and a case management approach. [ABSTRACT FROM AUTHOR]

The article presents a case study of managing a partial-thickness corneal laceration in a 28-year-old white male presented with the complaint of a scratched right eye. He was prescribed with ciprofloxacin, prednisolone acetate, Muro sodium chloride hypertonicity ophthalmic ointment and homatropine. He reported that his eye felt better upon returning for a follow-up visit. The article discusses the possibility of full-thickness penetration of corneal laceration.

The article presents a case of a 27-year-old female who was rushed to a pediatric ophthalmologist due to constant diplopia eight months after her traumatic brain injury (TBI). Her relevant injuries included subdural hematoma, basilar skull fracture, and subarachnoid hemorrhage. She was diagnosed with esotropia and right hypotropia and underwent surgery. She was eventually diagnosed with anterior segment ischemia (ASI) following a three-muscle strabismus surgery.

The article describes the case of a 13-year-old girl, who developed bilateral 360-degree subconjunctival hemorrhages that later evolved to corneal epithelial defects, pseudo-membrane formation, and extensive oral mucosal ulcerations. Topics covered include information about Mycoplasma-induced rash and mucositis (MIRM), and data showing that aggressive lubrication combined with topical steroids and antibiotics improves chances of recovery.

The article discusses several ways for optometrists to treat patients having the uveitis. Topics discussed include immediate treatment of posterior synechiae that may lead to glaucoma or intraocular hypertension using cycloplegic agents, procedure to break pre-formed dense synechia with the help of a pledget, greater potency and efficacy of anti-inflammatory corticosteroids difluprednate rather than prednisolone acetate as per various studies, and determination of underlying systemic etiology.

The article examines the attributes of perennial allergy and reviews current and potential therapies designed to combat the chronic inflammation it engenders. It discusses the role of dust mites and animal danger as primary source of perennial indoor allergens. Therapies include glucocorticoids, dexamethasone, and prednisolone. Also discussed are the clinical models and the portention of combined antihistamine-calcineurin inhibitor as a treatment potential.

The article discusses a 2021 retrospective study which compared dexamethasone ophthalmic insert (Dextenza; Ocular Therapeutix Inc) with topical prednisolone on inflammation control during cataract surgery. It states that the 2 treatments' effects were similar to minimally invasive glaucoma surgeries (MIGS), and that the dexamethasone implant can address inflammation postoperatively without instillation of drops. Also noted is the latter's apparent effectivity as an alternative therapy.

The article discusses a research study on facial nerve palsy with specific focus on the seventh cranial nerve (CN VII) palsy. Topics discussed include its symptoms, pathophysiology and treatment available for it. A dose of prednisolone is recommended for its treatment and alternate therapies are also suggested such as acupuncture, hyperbaric oxygen therapy and physical therapy.

The article presents a case study of an 82-year-old retired nun diagnosed with herpes zoster ophthalmicus, a common disease in older people. It says that the patient had dementia and was referred for evaluation of right visual loss and ophthalmoplegia. It adds that the patient was prescribed to use IV acyclovir, topical prednisolone, and cyclopentolate eye drops.

The article focuses on various pharmaceutical interventions in managing ocular inflammation immune response. It explores several pharmaceutical solutions for ocular inflammation including prednisolone acetate 1%, difluprednate emulsion, and dexamethasone. Topics include cataract formation, fluorometholone, and loteprednol etabonate.

The article discusses a study led by Dr. Helga Sandoval of the Medical University of Soth Carolina that assessed the efficacy of the combination drop therapy compared to the standard prophylactic treatment of gatifloxacin, bromfenac and prednisolone post cataract surgery. Outcome measures include intra-ocular pressure measurement, retinal thickness and pain. Results showed that combination drug therapy as prophylactic treatment provided similar results with standard individual drug regiments.

The article discusses a study led by Dr. Cynthia Matossian that compared the use of dexamethasone intraocular suspension (Dexycu) versus prednisolone acetate to manage post-operative increased intra-ocular pressure (IOP) in cataract patients. The study found that a singe dose of dexamethasone affects the intra-ocular pressure the same way as short term prednisolone acetate. It concludes that decreasing post-operative drop burden and increasing compliance can be accomplished with Dexycu.

The article discusses a simple postoperative protocol for cataract and refractive surgery patients which improves postsurgical experience. Topics covered include the good and poorer adherences in once-daily and complex dosing regimens, respectively, challenges in affordability, and extension of efficacy. Also noted are the development of a hybrid solution of injecting Tri-Moxi DropLess medication at the time of cataract surgery, and the use of Pred-Gati-Brom after LASIK surgery.

The article presents a case study of a 43-year-old white male presented to clinic with an irritated, red and teary right eye. It states that the patient was diagnosed of acute conjunctivitis and prescribed topical prednisolone acetate. It mentions that the patient was diagnosed with epidemic keratoconjunctivitis (EKC) and discusses the occurrence of adenoviral infections.

The article reports that U.S. Food and Drug Administration (FDA) has approved new gene therapy voretigene neparvovecrzyl (Luxturna), manufactured by Spark Therapeutics, which administered into the eye, targeting diseases caused by mutations in the gene RPE65. It mentions RPE65 gene provides genetic instructions for making an enzyme that converts light to an electrical signal in the retina and treatment is followed by a short course of oral prednisolone.

The article discusses a study on the association of prednisolone therapy in early stages of dengue infection with any adverse effects or delayed viral clearance.